摘要
宫颈癌(Cervical Cancer, CC)是世界范围中最常见的女性恶性肿瘤。为了对宫颈癌患者进行精确的个体化治疗,除加强生殖健康教育外,须采取相应的预防措施及早诊断早治疗,同时迫切需要找到合适的标记物进行较为准确的预后评估。当前大多数研究认为中性粒细胞、淋巴细胞、血小板等血液参数指标参与了肿瘤的形成进展以及转移的全过程。本文将围绕中性粒淋巴细胞比值(Neutrophil to Lymphocyte Ratio, NLR)、血小板淋巴细胞比值(Platelet to Lymphocyte Ratio, PLR)展开讨论,详细阐述术前血清学检测与宫颈癌发生、发展的相关性。
Cervical cancer (CC) is the most common female malignant tumor worldwide. In order to accurately individualize the treatment of cervical cancer patients, in addition to strengthening reproductive health education, it is necessary to take appropriate preventive measures for early diagnosis and treatment, and there is an urgent need to find appropriate markers for more accurate prognosis assessment. Most of the current studies believe that blood parameters such as neutrophils, lym-phocytes and platelets are involved in the whole process of tumor formation and progression as well as metastasis. In this paper, we will discuss the Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR), and elaborate the correlation between preoperative serologic testing and cervical cancer occurrence and development.
出处
《临床医学进展》
2023年第11期18162-18168,共7页
Advances in Clinical Medicine
